Randy C. Bowen

1.2k total citations · 1 hit paper
36 papers, 819 citations indexed

About

Randy C. Bowen is a scholar working on Ophthalmology, Oncology and Epidemiology. According to data from OpenAlex, Randy C. Bowen has authored 36 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Ophthalmology, 13 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Randy C. Bowen's work include Ocular Oncology and Treatments (14 papers), Retinal Diseases and Treatments (4 papers) and Cutaneous Melanoma Detection and Management (4 papers). Randy C. Bowen is often cited by papers focused on Ocular Oncology and Treatments (14 papers), Retinal Diseases and Treatments (4 papers) and Cutaneous Melanoma Detection and Management (4 papers). Randy C. Bowen collaborates with scholars based in United States, Canada and Norway. Randy C. Bowen's co-authors include Jared McAllister, Aaron M. Chamberlain, Gregory C. Ebersole, Jay D. Keener, Robert Z. Tashjian, Erin K. Granger, Man Hung, Wei Chen, Arun D. Singh and Hung T. Khong and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and American Journal of Ophthalmology.

In The Last Decade

Randy C. Bowen

35 papers receiving 793 citations

Hit Papers

Determining the minimal clinically important difference f... 2016 2026 2019 2022 2016 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Randy C. Bowen United States 12 373 309 183 154 80 36 819
William W. Dzwierzynski United States 18 366 1.0× 158 0.5× 202 1.1× 15 0.1× 43 0.5× 58 894
Winnie Tong Australia 15 401 1.1× 293 0.9× 202 1.1× 24 0.2× 42 0.5× 42 800
Maziar Shafighi Switzerland 17 385 1.0× 95 0.3× 99 0.5× 19 0.1× 70 0.9× 49 766
Matteo Coen Switzerland 16 170 0.5× 117 0.4× 42 0.2× 12 0.1× 82 1.0× 57 756
Seyedeh Tahereh Faezi Iran 16 74 0.2× 35 0.1× 34 0.2× 129 0.8× 107 1.3× 59 639
Feride Göğüş Türkiye 12 76 0.2× 80 0.3× 18 0.1× 197 1.3× 87 1.1× 41 718
James Kim United States 13 308 0.8× 31 0.1× 76 0.4× 83 0.5× 10 0.1× 33 562
Kibwei A. McKinney United States 20 582 1.6× 286 0.9× 105 0.6× 17 0.1× 72 0.9× 42 1.1k
Nevin Hammam Egypt 15 281 0.8× 53 0.2× 42 0.2× 16 0.1× 95 1.2× 49 800

Countries citing papers authored by Randy C. Bowen

Since Specialization
Citations

This map shows the geographic impact of Randy C. Bowen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randy C. Bowen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randy C. Bowen more than expected).

Fields of papers citing papers by Randy C. Bowen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randy C. Bowen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randy C. Bowen. The network helps show where Randy C. Bowen may publish in the future.

Co-authorship network of co-authors of Randy C. Bowen

This figure shows the co-authorship network connecting the top 25 collaborators of Randy C. Bowen. A scholar is included among the top collaborators of Randy C. Bowen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randy C. Bowen. Randy C. Bowen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bowen, Randy C., Paul J. Bryar, & Pedram Gerami. (2025). Imiquimod Treatment for Conjunctival Melanoma In Situ or Ocular Surface Squamous Neoplasia. JAMA Ophthalmology. 144(1). 42–42.
2.
Bowen, Randy C., et al.. (2024). Ocular inflammatory myofibroblastic tumor in a pediatric patient. Journal of American Association for Pediatric Ophthalmology and Strabismus. 28(1). 103821–103821. 1 indexed citations
3.
Bowen, Randy C., et al.. (2021). Photodynamic therapy for choroidal melanoma: What is the response rate?. Survey of Ophthalmology. 66(4). 552–559. 17 indexed citations
4.
Bowen, Randy C., et al.. (2021). Uveal Melanoma: Refusal of Treatment. Ocular Oncology and Pathology. 7(5). 361–367. 7 indexed citations
5.
Bowen, Randy C., et al.. (2021). Ocular surface squamous neoplasia: outcomes following primary excision with 2 mm margin and cryotherapy. Eye. 35(11). 3102–3109. 11 indexed citations
6.
Bowen, Randy C., et al.. (2021). Choroidal macrovessel: Systematic review and analysis of anatomic origin. Survey of Ophthalmology. 67(2). 570–578. 3 indexed citations
7.
Bowen, Randy C., et al.. (2021). Presumed Melanoma of Unknown Primary Origin Metastatic to the Choroid Mimics Primary Uveal Melanoma. Case Reports in Ophthalmology. 12(3). 987–993. 2 indexed citations
8.
Bowen, Randy C., H. Culver Boldt, Robert F. Mullins, et al.. (2021). Intrafamilial Variability of Ocular Manifestations of von Hippel-Lindau Disease. Ophthalmology Retina. 6(1). 89–91. 1 indexed citations
9.
Raval, Vishal, et al.. (2020). Intravenous Chemotherapy for Retinoblastoma in the Era of Intravitreal Chemotherapy: A Systematic Review. Ocular Oncology and Pathology. 7(2). 142–148. 8 indexed citations
10.
Bowen, Randy C., et al.. (2020). Primary acquired melanosis/melanoma: utility of conjunctival map biopsy. British Journal of Ophthalmology. 106(5). 605–609. 3 indexed citations
11.
Singh, Nakul, et al.. (2020). Uveal Melanoma in BAP1 Tumor Predisposition Syndrome: Estimation of Risk. American Journal of Ophthalmology. 224. 172–177. 18 indexed citations
12.
Bowen, Randy C., et al.. (2019). Personalized Treatment for Lacrimal Sac Adenoid Cystic Carcinoma: Case Report and Literature Review. Practical Radiation Oncology. 9(3). 136–141. 4 indexed citations
13.
Bowen, Randy C., Junjie Ma, Bradley J. Katz, et al.. (2018). The Most Common Causes of Eye Pain at 2 Tertiary Ophthalmology and Neurology Clinics. Journal of Neuro-Ophthalmology. 38(3). 320–327. 21 indexed citations
14.
Chamberlain, Aaron M., Man Hung, Wei Chen, et al.. (2017). Determining the Patient Acceptable Symptomatic State for the ASES, SST, and VAS Pain After Total Shoulder Arthroplasty. SHILAP Revista de lepidopterología. 1. 32 indexed citations
15.
Tashjian, Robert Z., Man Hung, Jay D. Keener, et al.. (2016). Determining the minimal clinically important difference for the American Shoulder and Elbow Surgeons score, Simple Shoulder Test, and visual analog scale (VAS) measuring pain after shoulder arthroplasty. Journal of Shoulder and Elbow Surgery. 26(1). 144–148. 325 indexed citations breakdown →
17.
Bowen, Randy C., Andrew W. Hahn, Thomas W. Butler, & Hung T. Khong. (2016). Complete response to azacitidine priming and nab-paclitaxel in non-Hodgkin lymphoma resistant to biochemotherapy. Molecular and Clinical Oncology. 6(1). 122–124. 4 indexed citations
18.
Bowen, Randy C., et al.. (2015). Assessing ocular hyaluronidase to develop a hyaluronan-based polymer drug delivery platform. Investigative Ophthalmology & Visual Science. 56(7). 1295–1295. 2 indexed citations
19.
Bowen, Randy C., et al.. (2015). Clinical and Neurobiological Perspectives of Empowering Pediatric Cancer Patients Using Videogames. Games for Health Journal. 4(5). 362–374. 33 indexed citations
20.
Bowen, Randy C., et al.. (1965). Radiotherapy of cerebral metastases.. PubMed. 61(12). 894–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026